FDA Could Authorize Novavax COVID Vaccine by February, But Is It ‘Safe and Effective?’

The U.S. Food and Drug Administration could authorize the Novavax vaccine by February. Unlike the Pfizer and Moderna mRNA vaccines, Novavax relies on more conventional vaccine technology shown in clinical trials to have fewer side effects, but safety of spike protein still in question.

Read the article at The Defender